The filings show a revenue number; the web shows a business under acute stress. FY2025 revenue rose 42.9% to RM14.92B — but net income collapsed 47.1% to RM227M, Q4 2025 profit fell ~80% YoY, and five-year ROCE has decayed from 22% to 7%. Operating leverage reversed, free cash flow went to zero in FY2024, and the share price halved in 2025 as chocolate makers delayed purchases and reformulated away from cocoa at record bean prices. The open question the filings can't answer: is this a cyclical trough (bean-price normalization heals it) or a structural re-rating (customers permanently re-engineered recipes)?
**#1 — Earnings quality broke in FY2025.** Revenue +42.9% to RM14.92B, net income −47.1% to RM227M. Q4 2025 net income was just RM43M vs RM213M in Q4 2024 (−80%). Headline was further hit by a "significant unrealised fair value loss" on commodity/derivative positions. Sources: [stockanalysis.com](https://stockanalysis.com/quote/klse/GCB/statistics/), [cbinsights](https://www.cbinsights.com/company/guan-chong-berhad).
**#2 — ROCE collapse over 5 years: 22% → 7%.** Simply Wall St flags this as structural capital-efficiency decay, not a one-off. Pair that with FY2024 accrual ratio of **0.45** (high accruals = low earnings quality) and **zero free cash flow in FY2024** despite reported EPS of RM0.36. Source: [simplywall.st](https://simplywall.st/stocks/my/food-beverage-tobacco/klse-gcb/guan-chong-berhad-shares), [finance.yahoo.com](https://finance.yahoo.com/news/impressive-earnings-may-not-tell-231406673.html).
**#3 — Demand destruction from customers.** H2 2025 grinding volumes "remained pressured as chocolate makers delayed purchases and reformulated amid high bean prices." Cocoa butter and cocoa powder volumes both softened. This is a pricing-power ceiling the filings downplay. Source: [cbinsights](https://www.cbinsights.com/company/guan-chong-berhad), [i3investor](https://klse.i3investor.com/web/stock/overview/5102).
**#4 — Consensus FY2027 revenue forecast is RM7.85B — a 47% contraction from FY2025.** Analysts are not modelling current revenue as sustainable; they expect bean-price normalization to pull reported revenue back hard, even though volume declines are also in the forecast. Source: [fintel.io](https://fintel.io/sfo/my/gcb).
**#5 — CEO insider buy, April 6, 2026.** Tay Hoe Lian (Managing Director/CEO since 2005) purchased 200,000 shares at **RM0.710**, after the stock had cratered from the RM3+ range. Small size, but a directional signal from a long-tenured founder-operator. Source: [i3investor](https://klse.i3investor.com/web/stock/overview/5102).
**#6 — Ivory Coast opportunity: further Transcao stake on the table.** Reuters reported Oct 10, 2024 that Ivory Coast's regulator may sell GCB an *additional* stake in state-backed processor Transcao CI (GCB already owns 25% acquired for USD 28.9M / RM130.1M). This is the biggest strategic growth vector in the pipeline and directly responsive to origin-country processing trends. Source: [reuters.com](https://www.reuters.com/markets/commodities/ivory-coast-eyes-further-asian-expertise-expand-cocoa-processing-2024-10-10/).
**#7 — Leverage still elevated even after improvement.** Net gearing improved to **1.38x** (from 1.89x) and total borrowings fell from RM4.26B to **RM3.25B** as bean prices eased working capital. But a ~RM300M sukuk issuance (half to refinance) is planned for UK/Germany expansion, and the RM800M sukuk program remains MARC AA-IS rated. Source: [marc.com.my](https://www.marc.com.my/rating-announcements/marc-ratings-affirms-aa-is-rating-on-guan-chongs-rm800-0-million-sukuk-programme/).
**#8 — Analyst consensus: BUY with ~RM1.53 mean target vs RM0.835 spot (44–83% implied upside).** But coverage is thin (2 analysts) and targets were cut alongside revenue upgrades late 2025 — unusual divergence suggesting analysts see the revenue print as low-quality. Simply Wall St's DDM prints fair value at **RM0.63**; its 2-stage FCF-to-equity model prints **RM1.84**. The spread tells you how model-assumption-dependent this stock is. Sources: [marketscreener.com](https://www.marketscreener.com/quote/stock/GUAN-CHONG-6498361/), [simplywall.st](https://simplywall.st/stocks/my/food-beverage-tobacco/klse-gcb/guan-chong-berhad-shares).
**#9 — Data breach disclosed Dec 23, 2025.** Surface reports on breachsense.com; no quantified impact yet, but a governance/ops red flag worth tracking. Source: [breachsense.com](https://www.breachsense.com/breaches/guan-chong-berhad-data-breach/).
**#10 — Entrenched management concentration.** CEO Tay Hoe Lian, COO Tay How Sik, CFO Cheng Hia all appointed Jan 7, 2005 — 20+ year tenure. Guan Chong Resources Sdn Bhd holds **~50%**, direct insider holdings add **~22%**. Independent directors were only 33% of board in the latest granular disclosure (2015); current board is 7 with mixed independence. Source: [marketscreener.com](https://www.marketscreener.com/quote/stock/GUAN-CHONG-6498361/), [gcb.net.my governance](http://gcb.net.my/corporate-governance.html).
Key read: the board is founder-family-anchored and extraordinarily tenured. The only insider activity that registered in the last three months is the CEO's April 6, 2026 buy of 200,000 shares at RM0.710 — a modest but directional signal from a 20-year operator who already owns ~4.9% of the company.
Cocoa bean prices peaked near USD 12,565/t in 2024 before easing into 2025 — a historic spike that lifted all processors' reported revenue while simultaneously triggering customer reformulation. Regional processors (GCB, JB Cocoa, Transcao) are gaining share against the Barry Callebaut / Cargill / Olam / ADM global majors specifically on origin-country cost, traceability, and expanding export capability. Ivory Coast's regulator (Conseil du Café-Cacao) is actively soliciting Asian capital and expertise — the Transcao partnership is the template, and the additional-stake dialogue with GCB is the most important strategic file on the desk.
The 2024–2025 demand shock — chocolate makers reformulating away from high-cocoa recipes — is the structural overhang. The consensus FY2027 revenue of RM7.85B (down 47% vs FY2025) is the market's way of saying it doesn't believe the volume side of this business comes back cleanly. Whether that's right is the central question the filings can't settle.